ArticleProceedings of the National Academy of Sciences of the United States of America2008

In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of beta-thalassemia.

Annarita Miccio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.